Similar articles

• Autoantibody-mediated disorders of the central nervous system.

  Irani S, Lang B. Irani S, et al. Autoimmunity. 2008 Feb;41(1):55-65. doi: 10.1080/08916930701619490. Autoimmunity. 2008. PMID: 18176865 Review.
• Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.

  Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H. Ishida K, et al. Ann Neurol. 1999 Aug;46(2):263-7. Ann Neurol. 1999. PMID: 10443895
• Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.

  Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, Yaguchi M, Ishida K, Shoji M, Tanaka M, Mizusawa H, Okamoto K. Takenoshita H, et al. J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):386-9. doi: 10.1136/jnnp.70.3.386. J Neurol Neurosurg Psychiatry. 2001. PMID: 11181864 Free PMC article.
• New autoantibody mediated disorders of the central nervous system.

  Lang B, Dale RC, Vincent A. Lang B, et al. Curr Opin Neurol. 2003 Jun;16(3):351-7. doi: 10.1097/01.wco.0000073937.19076.d5. Curr Opin Neurol. 2003. PMID: 12858073 Review.
• Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.

  Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F. Saiz A, et al. Brain. 2008 Oct;131(Pt 10):2553-63. doi: 10.1093/brain/awn183. Epub 2008 Aug 7. Brain. 2008. PMID: 18687732